Celera and Ipsen to Develop Biomarkers, PGx Tests for Growth Failure Therapies

Nov 21, 2007

NEW YORK (GenomeWeb News) - Celera will help Ipsen develop pharmacogenomic tests that could be used in tandem with Ipsen’s hormone-replacement therapies for short stature, the companies said yesterday.

Under the first phase of the multi-year collaboration, Celera will work with the Paris-based specialty pharmaceutical company to locate and characterize genetic markers related to growth failure.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

The Fall of the Yellow-Banded Bumblebee

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

If It Is to Help

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

Bunch at Once

The Scientist reports agricultural researchers are working on a gene-stacking tool.

This Week in Nature

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.

Main menu